The pharmaceutical sector has come under ever-greater scrutiny in recent years, as more and more counterfeit products infiltrate legitimate supply chains.

Life sciences companies need to draw on the tools and protections in their supplier contracts to maintain continuity and minimize disruption.

The importation of fake and fraudulent medical supplies must be stopped.

Companies make thousands of decisions a day about what to produce, where to put product and what to promote. But they often make those decisions based on very limited information.

The all-cash takeover could be one of the largest U.K. take-private deals this year.

A staggering 93% of chemical companies claim freight transportation and supply chain disruptions have affected them negatively.

The FDA has long been criticized for lapses in inspections of overseas manufacturing in China and India, which are the two major producers of drugs and raw ingredients for medicines.

The deal would bolster Sartorius’s portfolio of drug-delivery technologies, creating a deeper focus on the fast-growing field of viral vectors, which are tools used to deliver genetic material into cells.

A ransomware group has claimed responsibility for the incident, which included a breach of some file systems and theft of certain company and personal data.

Pfizer has been under pressure to show it can capitalize on its COVID-19 windfall, after vaccine revenue almost doubled its sales in a single year.